The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
Dosage form
Solution for injection 2 ml or 4 ml №10.
Active ingredient
1 ml contains tiazotic acid morpholinium salt, in terms of 100% of the substance, 25 mg, which is equivalent to 16.6 mg of tiazotic acid.
Indications
In the complex treatment of ischemic heart disease: angina, myocardial infarction, postinfarction cardiosclerosis; as additional treatment in the treatment of cardiac arrhythmias. In the complex treatment of chronic hepatitis, alcoholic hepatitis, liver fibrosis and cirrhosis.

If you have information about any adverse effects or other drug-related problems, please fill in the form